世界のテデュグルチド市場:成長動向・競争分析2020-2026

【英語タイトル】Global Teduglutide Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP02410)・商品コード:QYR20AP02410
・発行会社(調査会社):QYResearch
・発行日:2020年3月23日
・ページ数:115
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥676,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,014,300見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,352,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、テデュグルチドの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、テデュグルチドのグローバル市場動向、メーカー別競争状況、種類別市場規模(ガテックス、リベスティブ)、用途別市場規模(病院、薬局、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・テデュグルチドの種類別市場2015-2026:ガテックス、リベスティブ
・テデュグルチドの用途別市場2015-2026:病院、薬局、その他
・テデュグルチドの北米市場分析
・テデュグルチドのアジア市場分析
・テデュグルチドの中南米市場分析
・テデュグルチドの中東・アフリカ市場分析
・関連企業情報:Takeda Pharmaceuticals
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Teduglutide (brand names Gattex in the US and Revestive in Europe) is a 33-membered polypeptide and glucagon-like peptide-2 (GLP-2) analog that is used for the treatment of short bowel syndrome.In 2019, the global Teduglutide market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Teduglutide.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Teduglutide market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Teduglutide market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Teduglutide market. Readers of the report can become informed about current and future trends of the global Teduglutide market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Teduglutide markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Teduglutide market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Teduglutide market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Teduglutide market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Teduglutide market is segmented into
Gattex
Revestive

Market Segment by Application, the Teduglutide market is segmented into
Hospital
Pharmacy
Other

This report includes the following manufacturers; we can also add the other companies as you want.
Takeda Pharmaceuticals

The study objectives are:
To analyze and research the global Teduglutide status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Teduglutide manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Teduglutide are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Teduglutide Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Teduglutide Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Gattex
1.3.3 Revestive
1.4 Market Segment by Application
1.4.1 Global Teduglutide Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospital
1.4.3 Pharmacy
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Teduglutide Revenue (2015-2026)
2.1.1 Global Teduglutide Revenue (2015-2026)
2.1.2 Global Teduglutide Sales (2015-2026)
2.2 Teduglutide Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Teduglutide Sales by Regions (2015-2020)
2.2.2 Global Teduglutide Revenue by Regions (2015-2020)
2.3 Global Top Teduglutide Regions (Countries) Ranking by Market Size
2.4 Teduglutide Industry Trends
2.4.1 Teduglutide Market Top Trends
2.4.2 Market Drivers
2.4.3 Teduglutide Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Teduglutide Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Teduglutide Manufacturers by Sales (2015-2020)
3.1.1 Global Teduglutide Sales by Manufacturers (2015-2020)
3.1.2 Global Teduglutide Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Teduglutide Sales in 2019
3.2 Global Top Manufacturers Teduglutide by Revenue
3.2.1 Global Teduglutide Revenue by Manufacturers (2015-2020)
3.2.2 Global Teduglutide Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Teduglutide Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Teduglutide as of 2019)
3.4 Global Teduglutide Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Teduglutide Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Teduglutide Market
3.7 Key Manufacturers Teduglutide Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Teduglutide Historic Market Review by Type (2015-2020)
4.1.2 Global Teduglutide Sales Market Share by Type (2015-2020)
4.1.3 Global Teduglutide Revenue Market Share by Type (2015-2020)
4.1.4 Teduglutide Price by Type (2015-2020)
4.1 Global Teduglutide Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Teduglutide Sales Forecast by Type (2021-2026)
4.2.3 Global Teduglutide Revenue Forecast by Type (2021-2026)
4.2.4 Teduglutide Price Forecast by Type (2021-2026)

5 Global Teduglutide Market Size by Application
5.1 Global Teduglutide Historic Market Review by Application (2015-2020)
5.1.2 Global Teduglutide Sales Market Share by Application (2015-2020)
5.1.3 Global Teduglutide Revenue Market Share by Application (2015-2020)
5.1.4 Teduglutide Price by Application (2015-2020)
5.2 Global Teduglutide Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Teduglutide Sales Forecast by Application (2021-2026)
5.2.3 Global Teduglutide Revenue Forecast by Application (2021-2026)
5.2.4 Teduglutide Price Forecast by Application (2021-2026)

6 North America
6.1 North America Teduglutide Breakdown Data by Company
6.2 North America Teduglutide Breakdown Data by Type
6.3 North America Teduglutide Breakdown Data by Application
6.4 North America Teduglutide Breakdown Data by Countries
6.4.1 North America Teduglutide Sales by Countries
6.4.2 North America Teduglutide Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Teduglutide Breakdown Data by Company
7.2 Europe Teduglutide Breakdown Data by Type
7.3 Europe Teduglutide Breakdown Data by Application
7.4 Europe Teduglutide Breakdown Data by Countries
7.4.1 Europe Teduglutide Sales by Countries
7.4.2 Europe Teduglutide Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Teduglutide Breakdown Data by Company
8.2 Asia Pacific Teduglutide Breakdown Data by Type
8.3 Asia Pacific Teduglutide Breakdown Data by Application
8.4 Asia Pacific Teduglutide Breakdown Data by Regions
8.4.1 Asia Pacific Teduglutide Sales by Regions
8.4.2 Asia Pacific Teduglutide Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Teduglutide Breakdown Data by Company
9.2 Latin America Teduglutide Breakdown Data by Type
9.3 Latin America Teduglutide Breakdown Data by Application
9.4 Latin America Teduglutide Breakdown Data by Countries
9.4.1 Latin America Teduglutide Sales by Countries
9.4.2 Latin America Teduglutide Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Teduglutide Breakdown Data by Type
10.2 Middle East and Africa Teduglutide Breakdown Data by Application
10.3 Middle East and Africa Teduglutide Breakdown Data by Countries
10.3.1 Middle East and Africa Teduglutide Sales by Countries
10.3.2 Middle East and Africa Teduglutide Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Takeda Pharmaceuticals
11.1.1 Takeda Pharmaceuticals Corporation Information
11.1.2 Takeda Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Takeda Pharmaceuticals Teduglutide Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Takeda Pharmaceuticals Teduglutide Products and Services
11.1.5 Takeda Pharmaceuticals SWOT Analysis
11.1.6 Takeda Pharmaceuticals Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Teduglutide Sales Channels
12.2.2 Teduglutide Distributors
12.3 Teduglutide Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Teduglutide Sales Forecast (2021-2026)
13.1.1 Global Teduglutide Sales Forecast by Regions (2021-2026)
13.1.2 Global Teduglutide Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Teduglutide Sales Forecast (2021-2026)
13.2.2 North America Teduglutide Revenue Forecast (2021-2026)
13.2.3 North America Teduglutide Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Teduglutide Sales Forecast (2021-2026)
13.3.2 Europe Teduglutide Revenue Forecast (2021-2026)
13.3.3 Europe Teduglutide Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Teduglutide Sales Forecast (2021-2026)
13.4.2 Asia Pacific Teduglutide Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Teduglutide Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Teduglutide Sales Forecast (2021-2026)
13.5.2 Latin America Teduglutide Revenue Forecast (2021-2026)
13.5.3 Latin America Teduglutide Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Teduglutide Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Teduglutide Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Teduglutide Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Teduglutide Key Market Segments
Table 2. Ranking of Global Top Teduglutide Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Teduglutide Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Gattex
Table 5. Major Manufacturers of Revestive
Table 6. Global Teduglutide Market Share by Application 2019-2025 (K Units)
Table 7. Global Teduglutide Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 8. Global Teduglutide Sales by Regions 2015-2020 (K Units)
Table 9. Global Teduglutide Sales Market Share by Regions 2015-2020
Table 10. Global Teduglutide Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Teduglutide Revenue Market Share by Regions 2015-2020
Table 12. Top Teduglutide Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Teduglutide Key Drivers: Impact Analysis (2021-2026)
Table 15. Teduglutide Key Challenges
Table 16. Main Points Interviewed from Key Teduglutide Players: Views for Future
Table 17. Global Teduglutide Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Teduglutide Sales Share by Manufacturers (2015-2020)
Table 19. Teduglutide Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Teduglutide Revenue Share by Manufacturers (2015-2020)
Table 21. Global Teduglutide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Teduglutide as of 2019)
Table 23. Key Manufacturers Teduglutide Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 24. Key Manufacturers Teduglutide Plants/Factories Distribution
Table 25. Key Manufacturers Teduglutide Area Served
Table 26. Date of Key Manufacturers Enter into Teduglutide Market
Table 27. Key Manufacturers Teduglutide Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Gattex Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 30. Global Revestive Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 31. Global Teduglutide Sales (K Units) by Type (2015-2020)
Table 32. Global Teduglutide Sales Share by Type (2015-2020)
Table 33. Global Teduglutide Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Teduglutide Price (K Units) by Type (2015-2020)
Table 35. Global Teduglutide Sales (K Units) by Type (2021-2026)
Table 36. Global Teduglutide Sales Share by Type (2021-2026)
Table 37. Global Teduglutide Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Teduglutide Revenue Share by Type (2021-2026)
Table 39. Global Teduglutide Price (K Units) by Type (2021-2026)
Table 40. Global Teduglutide Sales (K Units) by Application (2015-2020)
Table 41. Global Teduglutide Sales Share by Application (2015-2020)
Table 42. Global Teduglutide Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Teduglutide Price by Application 2015-2020 (USD/Unit)
Table 44. Global Teduglutide Sales by Application (2015-2020) (K Units)
Table 45. Global Teduglutide Sales Share by Application (2015-2020)
Table 46. Global Teduglutide Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Teduglutide Revenue Share by Application (2021-2026)
Table 48. Global Teduglutide Price (K Units) by Application (2021-2026)
Table 49. North America Teduglutide Sales by Company (2015-2020) (K Units)
Table 50. North America Teduglutide Sales Market Share by Company (2015-2020)
Table 51. North America Teduglutide Sales by Type (2015-2020) (K Units)
Table 52. North America Teduglutide Sales Market Share by Type (2015-2020)
Table 53. North America Teduglutide Sales by Application (2015-2020) (K Units)
Table 54. North America Teduglutide Sales Market Share by Application (2015-2020)
Table 55. North America Teduglutide Sales by Countries (2015-2020) (K Units)
Table 56. North America Teduglutide Sales Market Share by Countries (2015-2020)
Table 57. North America Teduglutide Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Teduglutide Revenue Market Share by Countries (2015-2020)
Table 59. Europe Teduglutide Sales by Company (2015-2020) (K Units)
Table 60. Europe Teduglutide Sales Market Share by Company (2015-2020)
Table 61. Europe Teduglutide Sales by Type (2015-2020) (K Units)
Table 62. Europe Teduglutide Sales Market Share by Type (2015-2020)
Table 63. Europe Teduglutide Sales by Application (2015-2020) (K Units)
Table 64. Europe Teduglutide Sales Market Share by Application (2015-2020)
Table 65. Europe Teduglutide Sales by Countries (2015-2020) (K Units)
Table 66. Europe Teduglutide Sales Market Share by Countries (2015-2020)
Table 67. Europe Teduglutide Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Teduglutide Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Teduglutide Sales by Regions (2015-2020) (K Units)
Table 70. Asia Pacific Teduglutide Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Teduglutide Sales by Type (2015-2020) (K Units)
Table 72. Asia Pacific Teduglutide Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Teduglutide Sales by Application (2015-2020) (K Units)
Table 74. Asia Pacific Teduglutide Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Teduglutide Sales by Countries (2015-2020) (K Units)
Table 76. Asia Pacific Teduglutide Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Teduglutide Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Teduglutide Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Teduglutide Sales by Company (2015-2020) (K Units)
Table 80. Latin America Teduglutide Sales Market Share by Company (2015-2020)
Table 81. Latin America Teduglutide Sales by Type (2015-2020) (K Units)
Table 82. Latin America Teduglutide Sales Market Share by Type (2015-2020)
Table 83. Latin America Teduglutide Sales by Application (2015-2020) (K Units)
Table 84. Latin America Teduglutide Sales Market Share by Application (2015-2020)
Table 85. Latin America Teduglutide Sales by Countries (2015-2020) (K Units)
Table 86. Latin America Teduglutide Sales Market Share by Countries (2015-2020)
Table 87. Latin America Teduglutide Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Teduglutide Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Teduglutide Sales by Type (2015-2020) (K Units)
Table 90. Middle East and Africa Teduglutide Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Teduglutide Sales by Application (2015-2020) (K Units)
Table 92. Middle East and Africa Teduglutide Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Teduglutide Sales by Countries (2015-2020) (K Units)
Table 94. Middle East and Africa Teduglutide Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Teduglutide Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Teduglutide Revenue Market Share by Countries (2015-2020)
Table 97. Takeda Pharmaceuticals Company Details
Table 98. Takeda Pharmaceuticals Description and Business Overview
Table 99. Takeda Pharmaceuticals Teduglutide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Takeda Pharmaceuticals Teduglutide Sales Growth Rate (2015-2020)
Table 101. Takeda Pharmaceuticals Teduglutide Sales Market Share in Global Market
Table 102. Takeda Pharmaceuticals Recent Development
Table 103. Teduglutide Distributors List
Table 104. Teduglutide Customers List
Table 105. Global Teduglutide Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 106. Global Teduglutide Sales Forecast by Type 2021-2026 (K Units)
Table 107. Global Teduglutide Sales Forecast by Application 2021-2026 (K Units)
Table 108. Global Teduglutide Sales Forecast by Regions 2021-2026 (K Units)
Table 109. Global Teduglutide Revenue Forecast by Regions 2021-2026 (Million US$)
Table 110. North America Teduglutide Sales Forecast by Countries 2021-2026 (K Units)
Table 111. North America Teduglutide Revenue Forecast by Countries 2021-2026
Table 112. Europe Teduglutide Sales Forecast by Countries 2021-2026 (K Units)
Table 113. Europe Teduglutide Revenue Market Share Forecast by Countries 2021-2026
Table 114. Asia Pacific Teduglutide Sales Forecast by Regions 2021-2026 (K Units)
Table 115. Asia Pacific Teduglutide Revenue Forecast by Regions 2021-2026 (Million US$)
Table 116. Latin America Teduglutide Sales Forecast by Countries 2021-2026 (K Units)
Table 117. Latin America Teduglutide Revenue Forecast by Countries 2021-2026 (Million US$)
Table 118. Middle East and Africa Teduglutide Sales Forecast by Regions 2021-2026 (K Units)
Table 119. Middle East and Africa Teduglutide Revenue Forecast by Regions 2021-2026 (Million US$)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Teduglutide Product Picture
Figure 2. Global Teduglutide Sales Market Shar by Type 2015-2026
Figure 3. Gattex Figures
Figure 4. Revestive Figures
Figure 5. Global Teduglutide Sales Market Share by Application in 2019 & 2026
Figure 6. Hospital Use Case
Figure 7. Pharmacy Use Case
Figure 8. Other Use Case
Figure 9. Teduglutide Report Years Considered
Figure 10. Global Teduglutide Market Size 2015-2026 (Million US$)
Figure 11. Global Teduglutide Sales 2015-2020 (K Units)
Figure 12. Global Teduglutide Market Size Market Share by Regions 2015-2020
Figure 13. Global Teduglutide Sales Market Share by Regions in 2019
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Teduglutide Sales Share by Manufacturers in 2019
Figure 16. The 5 and 10 Largest Manufacturers in the World: Market Share by Teduglutide Sales in 2019
Figure 17. Teduglutide Value Share by Manufacturers in 2019
Figure 18. Teduglutide Revenue Share by Manufacturers In 2019
Figure 19. Teduglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Teduglutide Revenue Share by Type (2015-2020)
Figure 21. Global Teduglutide Revenue Growth Rate by Type in 2015 & 2019
Figure 22. Global Teduglutide Market Share by Price Range (2015-2020)
Figure 23. Global Teduglutide Revenue Share by Application (2015-2020)
Figure 24. Global Teduglutide Revenue Growth Rate by Application in 2015 & 2019
Figure 25. North America Teduglutide Revenue Growth Rate 2015-2020 (Million US$)
Figure 26. U.S. Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 28. Europe Teduglutide Revenue Growth Rate 2015-2020 (Million US$)
Figure 29. Germany Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 31. U.K. Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 32. Italy Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 33. Russia Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 34. Asia Pacific Teduglutide Revenue Growth Rate 2015-2020 (Million US$)
Figure 35. China Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 36. Japan Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 37. South Korea Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 38. India Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 39. Australia Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 40. Taiwan Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 41. Indonesia Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 42. Thailand Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 43. Malaysia Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 44. Philippines Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 45. Vietnam Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 46. Latin America Teduglutide Revenue Growth Rate 2015-2020 (Million US$)
Figure 47. Mexico Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 48. Brazil Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 49. Argentina Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 50. Middle East and Africa Teduglutide Revenue Growth Rate 2015-2020 (Million US$)
Figure 51. Turkey Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 52. Saudi Arabia Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.A.E Teduglutide Sales Growth Rate (2015-2020) (K Units)
Figure 54. Takeda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Teduglutide Value Chain
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. North America Teduglutide Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 59. North America Teduglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 60. Europe Teduglutide Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 61. Europe Teduglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 62. Asia Pacific Teduglutide Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 63. Asia Pacific Teduglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 64. Latin America Teduglutide Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 65. Latin America Teduglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 66. Middle East and Africa Teduglutide Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 67. Middle East and Africa Teduglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed


【掲載企業】

Takeda Pharmaceuticals

★調査レポート[世界のテデュグルチド市場:成長動向・競争分析2020-2026] (コード:QYR20AP02410)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のテデュグルチド市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆